Retinal Vascular Disease Symposium

Related

• 

  Efficacy and Safety of Biosimilar Ranibizumab-nuna and Ranibizumab-eqrn in Clnical Use by a Consortium of Retina Specialists

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2023

• 

  Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial

  Philip J. Ferrone, MD, FASRS

  Annual Meeting Talks

  2019

• 

  Response to Ranibizumab of Eyes With Pigment Epithelial Detachments, Including Eyes That Developed RPE Tears: Data From the HARBOR Study

  David A. Eichenbaum, MD, FASRS

  Annual Meeting Talks

  2016